The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025

Monday, January 22, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Jan. 22, 2018 /PRNewswire/ -- U.S. Cord Blood Banking Services Market Analysis By Bank Type, By Component (Cord

Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky,
New Jersey
), And Segment Forecasts, 2014 - 2025 Read the full report: The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025 Increasing awareness regarding long term benefits of cord blood storage, increasing number of service providers, reduction in cost involved in storage, and growing investment in public banking are the factors driving the market growth in the country. The U.S. cord blood banking market captures a significant share of the global cord blood banking industry. Factors such as high adoption rate for advanced technologies, growing per capita income, and increasing number of storage service providers can be attributable to the largest market share. Growing applications of cord blood in the treatment of several chronic disorders is expected to fuel the market. Currently cord blood is approved for usage in around 80 diseases. These disease include degenerative disorders such as cancers, immunodeficiency related disorders, and bone marrow disorders. Growing prevalence of such diseases and need for effective therapeutic treatments are expected to boost the number of units stored. A large number of ongoing clinical trials in phase II, III, and IV are showing a potential growth opportunity in the near future. Further Key Findings from the Report Suggest: • Private banking currently captures the largest revenue share and is expected to dominate the market throughout the forecast period • Large number of parents opting for private banking, high prices involved in collection, transport and storage, and increasing number of these type of service provides are the prime factors expected to result in swift growth of the segment during the forecast period • Increasing awareness, high government investment, and efforts to store genetically diverse cord blood units are the factors expected to boost the segment growth of public banking • Cord blood captured the largest market share in 2016 over cord tissue and placenta. Relatively easy license acquisition, affordability, and ease of storage are the factors driving the segment share. • Key market players include California Cryobank Stem Cell Services LLC; Cord Blood America, Inc.; StemCyte, Inc.; Norton Healthcare, Inc.; Cryo-Cell International, Inc., and Lifeforce Cryobank Sciences Inc.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store